HCW Biologics Inc.
NASDAQ:HCWB
0.34 (USD) • At close January 14, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | HCW Biologics Inc. |
Symbool | HCWB |
Munteenheid | USD |
Prijs | 0.342 |
Beurswaarde | 12,950,732 |
Dividendpercentage | 0% |
52-weken bereik | 0.276 - 2.52 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Hing C. Wong Ph.D. |
Website | https://www.hcwbiologics.com |
An error occurred while fetching data.
Over HCW Biologics Inc.
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)